GEFITINIB INHIBITS INVASIVE PHENOTYPE AND EPITHELIAL-MESENCHYMAL TRANSITION IN DRUG-RESISTANT NSCLC CELLS WITH MET AMPLIFICATION.

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.

Despite the initial response, all patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) eventually develop acquired resistance to EGFR tyrosine kinase inhibitors (TKIs).The EGFR-T790M secondary mutation is responsible for half of acquired resistance cases, while MET amplification has Paint Guns been associa

read more



Analytics: What Do Business Majors Need and Where Do They Get It?

Analytical skills are important for all business majors.Because of the statistical underpinnings, statisticians are a natural fit for the delivery of these skills.Unfortunately, there is a lack of common understanding of what skills and competencies are needed.This article has two primary objectives: determine how business analytics course offering

read more